Cara Therapeutics Raises $15 Million
Cara Therapeutics Inc., a Tarrytown, N.Y.-based biotech company focused on pain and inflammation, has raised $15 million in Series D funding. Rho Ventures led the round, and was joined by return backers Alta Biopharma, Ascent Biomedical Ventures, CT Innovations, Devon Park BioVentures, Healthcare Private Equity, Mitsubishi International Corporation and MVM Life Science Partners. The company previously raised $36.3 million.
21 July 2010•3 mins read
